News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
653,533 Results
Type
Article (32833)
Company Profile (640)
Press Release (620060)
Multimedia
Podcasts (55)
Webinars (11)
Section
Business (197786)
Career Advice (2156)
Deals (36163)
Drug Delivery (104)
Drug Development (78424)
Employer Resources (163)
FDA (15467)
Job Trends (14753)
News (333697)
Policy (28998)
Tag
Academia (1418)
Academic (1)
Accelerated approval (5)
Adcomms (13)
Allergies (86)
Alliances (46909)
ALS (94)
Alzheimer's disease (1322)
Antibody-drug conjugate (ADC) (139)
Approvals (15467)
Artificial intelligence (261)
Autoimmune disease (28)
Automation (15)
Bankruptcy (375)
Best Places to Work (11017)
BIOSECURE Act (22)
Biosimilars (99)
Biotechnology (437)
Bladder cancer (80)
Brain cancer (26)
Breast cancer (279)
Cancer (2216)
Cardiovascular disease (175)
Career advice (1780)
Career pathing (33)
CAR-T (153)
Cell therapy (436)
Cervical cancer (19)
Clinical research (64328)
Collaboration (864)
Company closure (1)
Compensation (545)
Complete response letters (27)
COVID-19 (2286)
CRISPR (42)
C-suite (260)
Cystic fibrosis (98)
Data (2181)
Decentralized trials (2)
Denatured (3)
Depression (50)
Diabetes (260)
Diagnostics (6366)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (120)
Drug pricing (103)
Drug shortages (24)
Duchenne muscular dystrophy (91)
Earnings (83590)
Editorial (37)
Employer branding (24)
Employer resources (139)
Events (111158)
Executive appointments (751)
FDA (16684)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (760)
Gene editing (109)
Generative AI (24)
Gene therapy (311)
GLP-1 (729)
Government (3060)
Grass and pollen (6)
Guidances (60)
Healthcare (16280)
Huntington's disease (23)
IgA nephropathy (30)
Immunology and inflammation (128)
Indications (30)
Infectious disease (2425)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (99)
Interviews (431)
IPO (17220)
IRA (41)
Job creations (4217)
Job search strategy (1478)
Kidney cancer (10)
Labor market (36)
Layoffs (541)
Leadership (19)
Legal (7151)
Liver cancer (73)
Lung cancer (309)
Lymphoma (144)
Machine learning (6)
Management (58)
Manufacturing (330)
MASH (67)
Medical device (13609)
Medtech (13614)
Mergers & acquisitions (19501)
Metabolic disorders (685)
Multiple sclerosis (83)
NASH (18)
Neurodegenerative disease (99)
Neuropsychiatric disorders (31)
Neuroscience (1885)
NextGen: Class of 2025 (6040)
Non-profit (2274)
Now hiring (40)
Obesity (366)
Opinion (249)
Ovarian cancer (72)
Pain (96)
Pancreatic cancer (83)
Parkinson's disease (150)
Partnered (19)
Patents (238)
Patient recruitment (112)
Peanut (49)
People (56958)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20193)
Phase II (28683)
Phase III (21378)
Pipeline (1223)
Policy (137)
Postmarket research (1965)
Preclinical (8136)
Press Release (64)
Prostate cancer (109)
Psychedelics (35)
Radiopharmaceuticals (263)
Rare diseases (380)
Real estate (5753)
Recruiting (64)
Regulatory (20773)
Reports (35)
Research institute (1483)
Resumes & cover letters (339)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (79)
Series A (140)
Series B (90)
Service/supplier (26)
Sickle cell disease (51)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (23)
Startups (3886)
State (2)
Stomach cancer (13)
Supply chain (72)
Tariffs (43)
The Weekly (51)
Vaccines (689)
Venture capitalists (44)
Weight loss (249)
Women's health (24)
Worklife (19)
Date
Today (155)
Last 7 days (952)
Last 30 days (2695)
Last 365 days (33598)
2025 (11021)
2024 (35982)
2023 (40550)
2022 (50794)
2021 (53987)
2020 (51162)
2019 (42466)
2018 (32498)
2017 (32685)
2016 (30882)
2015 (36338)
2014 (28938)
2013 (23790)
2012 (25436)
2011 (25657)
2010 (23436)
Location
Africa (686)
Alabama (59)
Alaska (6)
Arizona (164)
Arkansas (12)
Asia (40110)
Australia (6533)
California (6306)
Canada (2023)
China (537)
Colorado (272)
Connecticut (285)
Delaware (154)
Europe (87745)
Florida (885)
Georgia (204)
Hawaii (1)
Idaho (55)
Illinois (491)
India (29)
Indiana (320)
Iowa (12)
Japan (164)
Kansas (101)
Kentucky (24)
Louisiana (11)
Maine (66)
Maryland (798)
Massachusetts (4842)
Michigan (234)
Minnesota (401)
Mississippi (2)
Missouri (81)
Montana (30)
Nebraska (23)
Nevada (58)
New Hampshire (67)
New Jersey (1782)
New Mexico (30)
New York (1755)
North Carolina (1066)
North Dakota (7)
Northern California (2706)
Ohio (195)
Oklahoma (10)
Oregon (40)
Pennsylvania (1360)
Puerto Rico (12)
Rhode Island (35)
South America (1067)
South Carolina (22)
South Dakota (1)
Southern California (2324)
Tennessee (89)
Texas (927)
United States (23534)
Utah (182)
Virginia (150)
Washington D.C. (60)
Washington State (581)
West Virginia (3)
Wisconsin (62)
653,533 Results for "3m company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Synvect Secures $3M Seed Round to Combat Mosquito-Borne Diseases with CRISPR Technology
March 11, 2025
·
2 min read
Press Releases
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
April 14, 2025
·
4 min read
Business
3M Completes Spin-off of Solventum
3M completed the planned spin-off of its health care business, which formally launches Solventum Corporation as an independent company.
April 1, 2024
·
5 min read
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
January 29, 2025
·
6 min read
BioMidwest
3M Announces Upcoming Investor Event - May 13, 2024
3M announced the following investor event in partnership with Montrose Environmental Group, Inc.
May 13, 2024
·
1 min read
Press Releases
RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET
March 20, 2025
·
10 min read
Press Releases
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 16, 2024
·
7 min read
Press Releases
TearSolutions, Inc. Secures $3M Series B Funding
November 22, 2024
·
1 min read
Press Releases
VitriVax Awarded $3.6M Grant for Polio Vaccine Development
December 4, 2024
·
1 min read
Business
3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
3M reported first-quarter results and initiated its 2024 financial earnings outlook reflecting Solventum as a discontinued operation for the full-year, including Q1.
April 30, 2024
·
10 min read
1 of 65,354
Next
